{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T08:14:43Z","timestamp":1767168883668,"version":"build-2238731810"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:p>\n                    <jats:bold>\n                      <jats:italic>Background\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    Platelet-activating factor acetylhydrolase (PAF-AH), also denoted as lipoprotein-associated phospholipase A2, is a lipoprotein-bound enzyme that is possibly involved in inflammation and atherosclerosis. This study investigates the relationship of PAF-AH activity to angiographic coronary artery disease (CAD), the use of cardiovascular drugs, and other established risk factors.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>\n                      <jats:italic>Methods and Results\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    PAF-AH activity, lipoproteins, sensitive C-reactive protein (sCRP), fibrinogen, serum amyloid A, and white blood cell count were determined in 2454 subjects with angiographically confirmed CAD and in 694 control subjects. PAF-AH activity was highly correlated with LDL cholesterol (\n                    <jats:italic>r<\/jats:italic>\n                    =0.517), apolipoprotein B (\n                    <jats:italic>r<\/jats:italic>\n                    =0.644), and non-HDL cholesterol (\n                    <jats:italic>r<\/jats:italic>\n                    =0.648) but not with sCRP or fibrinogen. PAF-AH activity was lower in women than in men and was affected by the intake of lipid-lowering drugs (\u221212%;\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.001), aspirin (\u22126%;\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.001), \u03b2-blockers (\u22126%;\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.001), and digitalis (+7%;\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.001). Unlike sCRP, fibrinogen, and serum amyloid A, PAF-AH activity was not elevated in unstable angina, non\u2013ST-elevation myocardial infarction, or ST-elevation myocardial infarction. When nonusers of lipid-lowering drugs were examined, PAF-AH activity was associated with the severity of CAD and the number of coronary vessels with significant stenoses. In individuals not taking lipid-lowering drugs and after adjustment for use of aspirin, \u03b2-blocker, and digitalis, the odds ratio for CAD associated with increasing PAF-AH activity was 1.39 (95% CI 1.26 to 1.54,\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.001), a finding that was robust against further adjustments.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>\n                      <jats:italic>Conclusions\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    PAF-AH activity is not an indicator of the systemic inflammation that accompanies acute coronary syndromes. PAF-AH activity is affected by a number of cardiovascular drugs; however, after such medication use was accounted for, PAF-AH activity was associated with angiographic CAD, complementary to sCRP and independently of established risk factors such as LDL cholesterol.\n                  <\/jats:p>","DOI":"10.1161\/01.cir.0000156457.35971.c8","type":"journal-article","created":{"date-parts":[[2005,2,14]],"date-time":"2005-02-14T20:23:53Z","timestamp":1108412633000},"page":"980-987","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":98,"title":["Platelet-Activating Factor Acetylhydrolase Activity Indicates Angiographic Coronary Artery Disease Independently of Systemic Inflammation and Other Risk Factors"],"prefix":"10.1161","volume":"111","author":[{"given":"Karl","family":"Winkler","sequence":"first","affiliation":[{"name":"From the Department of Medicine, University of Freiburg, Freiburg, Germany (K.W., M.M.H., A.B.G., M.N.); Cardiology Group Frankfurt-Sachsenhausen, Frankfurt, Germany (B.R.W.); Clinical Institute of Medical and Chemical Laboratory Diagnostics, University of Graz, Graz, Austria (H.S., W.M.); and Division of Endocrinology and Diabetes, Department of Medicine, University of Ulm, Ulm, Germany (B.O.B.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard R.","family":"Winkelmann","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Freiburg, Freiburg, Germany (K.W., M.M.H., A.B.G., M.N.); Cardiology Group Frankfurt-Sachsenhausen, Frankfurt, Germany (B.R.W.); Clinical Institute of Medical and Chemical Laboratory Diagnostics, University of Graz, Graz, Austria (H.S., W.M.); and Division of Endocrinology and Diabetes, Department of Medicine, University of Ulm, Ulm, Germany (B.O.B.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert","family":"Scharnagl","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Freiburg, Freiburg, Germany (K.W., M.M.H., A.B.G., M.N.); Cardiology Group Frankfurt-Sachsenhausen, Frankfurt, Germany (B.R.W.); Clinical Institute of Medical and Chemical Laboratory Diagnostics, University of Graz, Graz, Austria (H.S., W.M.); and Division of Endocrinology and Diabetes, Department of Medicine, University of Ulm, Ulm, Germany (B.O.B.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Freiburg, Freiburg, Germany (K.W., M.M.H., A.B.G., M.N.); Cardiology Group Frankfurt-Sachsenhausen, Frankfurt, Germany (B.R.W.); Clinical Institute of Medical and Chemical Laboratory Diagnostics, University of Graz, Graz, Austria (H.S., W.M.); and Division of Endocrinology and Diabetes, Department of Medicine, University of Ulm, Ulm, Germany (B.O.B.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Busse","family":"Grawitz","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Freiburg, Freiburg, Germany (K.W., M.M.H., A.B.G., M.N.); Cardiology Group Frankfurt-Sachsenhausen, Frankfurt, Germany (B.R.W.); Clinical Institute of Medical and Chemical Laboratory Diagnostics, University of Graz, Graz, Austria (H.S., W.M.); and Division of Endocrinology and Diabetes, Department of Medicine, University of Ulm, Ulm, Germany (B.O.B.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Nauck","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Freiburg, Freiburg, Germany (K.W., M.M.H., A.B.G., M.N.); Cardiology Group Frankfurt-Sachsenhausen, Frankfurt, Germany (B.R.W.); Clinical Institute of Medical and Chemical Laboratory Diagnostics, University of Graz, Graz, Austria (H.S., W.M.); and Division of Endocrinology and Diabetes, Department of Medicine, University of Ulm, Ulm, Germany (B.O.B.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard O.","family":"Bo\u0308hm","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Freiburg, Freiburg, Germany (K.W., M.M.H., A.B.G., M.N.); Cardiology Group Frankfurt-Sachsenhausen, Frankfurt, Germany (B.R.W.); Clinical Institute of Medical and Chemical Laboratory Diagnostics, University of Graz, Graz, Austria (H.S., W.M.); and Division of Endocrinology and Diabetes, Department of Medicine, University of Ulm, Ulm, Germany (B.O.B.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winfried","family":"Ma\u0308rz","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Freiburg, Freiburg, Germany (K.W., M.M.H., A.B.G., M.N.); Cardiology Group Frankfurt-Sachsenhausen, Frankfurt, Germany (B.R.W.); Clinical Institute of Medical and Chemical Laboratory Diagnostics, University of Graz, Graz, Austria (H.S., W.M.); and Division of Endocrinology and Diabetes, Department of Medicine, University of Ulm, Ulm, Germany (B.O.B.)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1995.tb00894.x"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0952-3278(94)90101-5"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-1981(00)00114-1"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3380479"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7827(98)00009-5"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1997.1570706.x"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a003101"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01554-6"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000116763.91992.f1"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(99)00406-2"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200010193431603"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M300086-JLR200"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000143377.53389.c8"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1517\/14622416.2.1.S1"},{"key":"e_1_3_2_15_2","first-page":"7","volume":"50","year":"1975","unstructured":"Austen WG, Edwards JE, Frye RL, Gensini CG, Gott VL, Griffith LSC, McGoon DC, Murphy MC, Roe BB. A reporting system on patients evaluated for coronary artery disease: report of the ad hoc committee for grading of coronary artery disease. Circulation. 1975; 50 (suppl 5): 7\u201340.","journal-title":"Circulation"},{"key":"e_1_3_2_16_2","first-page":"78","volume":"170","year":"1970","unstructured":"Friesinger G, Page E, Ross R. Prognostic significance of coronary arteriography. Trans Assoc Am Physicians. 1970; 170: 78\u201392.","journal-title":"Trans Assoc Am Physicians"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(00)00216-3"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4838(90)90100-T"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1991.92"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000146898.06923.80"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(01)00612-X"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031494"},{"key":"e_1_3_2_23_2","first-page":"170","volume":"7","year":"1997","unstructured":"Patrick D, Moore E, Moore F, Biffl W, Barnett C. Reduced PAF-acetylhydrolase activity is associated with postinjury multiple organ failure. Shock. 1997; 7: 170\u2013174.","journal-title":"Shock"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.7.4012"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.11.1413"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00033-2"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)01638-1"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.15.10.1764"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.52.31151"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/345634a0"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.6.3.309"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.103.22.2705"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.18.2363"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-812396"},{"key":"e_1_3_2_36_2","first-page":"833","volume":"52","year":"2003","unstructured":"NHANES. Prevalence of diabetes and impaired fasting glucose in adults\u2014United States, 1999\u20132000. MMWR Morb Mortal Wkly Rep. 2003; 52: 833\u2013837.","journal-title":"MMWR Morb Mortal Wkly Rep"}],"updated-by":[{"DOI":"10.1161\/circulationaha.105.166889","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2005,6,21]],"date-time":"2005-06-21T00:00:00Z","timestamp":1119312000000}}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.0000156457.35971.C8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T08:54:44Z","timestamp":1715504084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.0000156457.35971.C8"}},"subtitle":["The Ludwigshafen Risk and Cardiovascular Health Study"],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1161\/01.CIR.0000156457.35971.C8"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.0000156457.35971.c8","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"2005-02-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}